How is non-CF bronchiectasis affecting Medicare spending and utilization?

AJMC reported that non-CF bronchiectasis is linked to high Medicare utilization and spending, putting the disease into sharper focus as a cost burden. The article says this could increase scrutiny on treatment patterns, avoidable medical use, and whether therapies can prove both clinical and economic value.